In a report released today, Matt McGinley from Needham assigned a Buy rating to Curaleaf Holdings (CURLF), with a price target of $10.70. The company’s shares closed last Monday at $5.90.
According to TipRanks.com, McGinley is a 4-star analyst with an average return of 19.2% and a 65.0% success rate. McGinley covers the Industrial Goods sector, focusing on stocks such as Green Thumb Industries, Trulieve Cannabis, and Aurora Cannabis.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Curaleaf Holdings with a $10.64 average price target, an 82.5% upside from current levels. In a report issued on June 8, Roth Capital also initiated coverage with a Buy rating on the stock with a $9.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $8.43 and a one-year low of $2.54. Currently, Curaleaf Holdings has an average volume of 541K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
Read More on CURLF:
